株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

深部脳刺激装置:医療機器のパイプライン評価

Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 347932
出版日 ページ情報 英文 119 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.76円で換算しております。
Back to Top
深部脳刺激装置:医療機器のパイプライン評価 Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017
出版日: 2017年09月08日 ページ情報: 英文 119 Pages
概要

当レポートでは、深部脳刺激装置のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 深部脳刺激装置の概要

第3章 開発中の製品

  • 深部脳刺激装置 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:地域別
  • 深部脳刺激装置 - パイプライン製品:規制別
  • 深部脳刺激装置 - パイプライン製品:承認予定日別
  • 深部脳刺激装置 - 進行中の臨床試験

第4章 深部脳刺激装置 - 開発中のパイプライン製品:企業別

  • 深部脳刺激装置企業 - パイプライン製品:開発段階別
  • 深部脳刺激装置 - パイプライン製品:開発段階別

第5章 深部脳刺激装置企業と製品の概要

  • Adaptive Neuromodulation GmbH
  • Aleva Neurotherapeutics SA
  • Boston Scientific Corporation
  • Brainsway Ltd.
  • Cerene Biomedics, Inc
  • Children's Hospital Boston
  • Cleveland Medical Devices, Inc.
  • Clinatec
  • Deep Brain Innovations, LLC
  • Duke University
  • Functional Neuromodulation Inc.
  • Highland Instruments, Inc.
  • Massachusetts General Hospital
  • Mayo Clinic.
  • Medtronic plc
  • National Cheng-Kung University Hospital
  • NeuroPro Technologies, Inc.
  • NeuroSigma, Inc.
  • Nuraleve Inc.
  • Soterix Medical Inc
  • St. Jude Medical, Inc.
  • SUNY Downstate Medical Center
  • The University of Utah
  • University of California, Los Angeles
  • University of Central Florida
  • University of Illinois
  • University of Milan
  • University of Oxford
  • University of South Florida
  • Wedge Therapeutics

第6章 深部脳刺激装置 - 最近の動向

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0437EPD

GlobalData's Medical Devices sector report, "Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017" provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Deep Brain Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Deep Brain Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Deep Brain Stimulators Overview 9

3 Products under Development 10

  • 3.1 Deep Brain Stimulators - Pipeline Products by Stage of Development 10
  • 3.2 Deep Brain Stimulators - Pipeline Products by Territory 11
  • 3.3 Deep Brain Stimulators - Pipeline Products by Regulatory Path 12
  • 3.4 Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 13
  • 3.5 Deep Brain Stimulators - Ongoing Clinical Trials 14

4 Deep Brain Stimulators - Pipeline Products under Development by Companies 15

  • 4.1 Deep Brain Stimulators Companies - Pipeline Products by Stage of Development 15
  • 4.2 Deep Brain Stimulators - Pipeline Products by Stage of Development 17

5 Deep Brain Stimulators Companies and Product Overview 19

  • 5.1 Adaptive Neuromodulation GmbH Company Overview 19
    • 5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 Aleva Neurotherapeutics SA Company Overview 20
    • 5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Boston Scientific Corp Company Overview 22
    • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 Brainsway Ltd Company Overview 29
    • 5.4.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.5 Cerene Biomedics, Inc. Company Overview 30
    • 5.5.1 Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Cerevast Therapeutics Inc Company Overview 31
    • 5.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.7 Children's Hospital Boston Company Overview 32
    • 5.7.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Cleveland Medical Devices Inc Company Overview 33
    • 5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Clinatec Company Overview 34
    • 5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.10 Deep Brain Innovations, LLC Company Overview 35
    • 5.10.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.11 Duke University Company Overview 40
    • 5.11.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.12 Functional Neuromodulation Inc. Company Overview 41
    • 5.12.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.13 Integer Holdings Corp Company Overview 44
    • 5.13.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.14 Iowa State University Company Overview 45
    • 5.14.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.15 Massachusetts General Hospital Company Overview 46
    • 5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.16 Massachusetts Institute of Technology Company Overview 48
    • 5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.17 Mayo Clinic US Company Overview 49
    • 5.17.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.18 Medtronic plc Company Overview 50
    • 5.18.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.19 National Cheng-Kung University Hospital Company Overview 55
    • 5.19.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.20 NeuroPro Technologies Inc Company Overview 56
    • 5.20.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.21 Neurosigma Inc Company Overview 57
    • 5.21.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.22 Newronika s.r.l. Company Overview 59
    • 5.22.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.23 Nexeon MedSystems Inc Company Overview 60
    • 5.23.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.24 Rio Grande Neurosciences, Inc. Company Overview 61
    • 5.24.1 Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 62
    • 5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.26 St. Jude Medical LLC Company Overview 64
    • 5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.27 SUNY Downstate Medical Center Company Overview 68
    • 5.27.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.28 University of California Los Angeles Company Overview 69
    • 5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.29 University of Central Florida Company Overview 71
    • 5.29.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.30 University of Illinois Company Overview 72
    • 5.30.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.31 University of Michigan Company Overview 73
    • 5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.32 University of Milan Company Overview 74
    • 5.32.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.33 University of Oxford Company Overview 75
    • 5.33.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.34 University of Rochester Company Overview 76
    • 5.34.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.35 University of South Florida Company Overview 77
    • 5.35.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.36 University of Utah Company Overview 80
    • 5.36.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.37 Wedge Therapeutics Company Overview 82
    • 5.37.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 82

6 Deep Brain Stimulators- Recent Developments 83

  • 6.1 Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 83
  • 6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 83
  • 6.3 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 86
  • 6.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 87
  • 6.5 Jun 12, 2017: Brainsway Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients 89
  • 6.6 Jun 06, 2017: Boston Scientific Receives CE Mark for Vercise Gevia Deep Brain Stimulation System 90
  • 6.7 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 91
  • 6.8 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 94
  • 6.9 Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry 95
  • 6.10 Apr 03, 2017: Sheppard Pratt Health System Appoints New Chief Operating Officer 96
  • 6.11 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 96
  • 6.12 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 99
  • 6.13 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 100
  • 6.14 Jan 11, 2017: Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent 101
  • 6.15 Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO 102
  • 6.16 Nov 28, 2016: Brainsway Reports Continued Financial Growth for Q3 of 2016 102
  • 6.17 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 103
  • 6.18 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 105
  • 6.19 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 106
  • 6.20 Nov 01, 2016: Sheppard Pratt Health System Appoints New Chief Financial Officer 107
  • 6.21 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 107
  • 6.22 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 109
  • 6.23 Oct 13, 2016: Baylor College of Medicine researcher and collaborators awarded grant through NIH BRAIN Initiative 110
  • 6.24 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 112
  • 6.25 Oct 07, 2016: Directional deep brain stimulation for movement disorders now being used 113
  • 6.26 Oct 06, 2016: St. Jude Medical Announces U.S. Launch and First Implant of New Deep Brain Stimulation System and Directional Lead for Patients Suffering from Movement Disorders 113
  • 6.27 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 114

7 Appendix 116

  • 7.1 Methodology 116
  • 7.2 About GlobalData 119
  • 7.3 Contact Us 119
  • 7.4 Disclaimer 119

List of Tables

1.1 List of Tables

  • Table 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 10
  • Table 2: Deep Brain Stimulators - Pipeline Products by Territory 11
  • Table 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 12
  • Table 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 13
  • Table 5: Deep Brain Stimulators - Ongoing Clinical Trials 14
  • Table 6: Deep Brain Stimulators Companies - Pipeline Products by Stage of Development 15
  • Table 7: Deep Brain Stimulators - Pipeline Products by Stage of Development 17
  • Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 9: CR-Capable Implant - Product Status 19
  • Table 10: CR-Capable Implant - Product Description 19
  • Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 12: directSTIM - Product Status 20
  • Table 13: directSTIM - Product Description 20
  • Table 14: spiderSTIM - Product Status 21
  • Table 15: spiderSTIM - Product Description 21
  • Table 16: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 17: Cartesia Directional Lead - Product Status 22
  • Table 18: Cartesia Directional Lead - Product Description 23
  • Table 19: Enspire DBS Therapy System - Stroke - Product Status 23
  • Table 20: Enspire DBS Therapy System - Stroke - Product Description 23
  • Table 21: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status 23
  • Table 22: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description 24
  • Table 23: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Status 24
  • Table 24: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Description 24
  • Table 25: Vercise Primary Cell Deep Brain Stimulation System - Product Status 25
  • Table 26: Vercise Primary Cell Deep Brain Stimulation System - Product Description 25
  • Table 27: Boston Scientific Corp - Ongoing Clinical Trials Overview 26
  • Table 28: Vercise Deep Brain Stimulation System - Parkinson's Disease - Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation: CLOVER 27
  • Table 29: Vercise Deep Brain Stimulation System - Parkinson's Disease - Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation 27
  • Table 30: Vercise Deep Brain Stimulation System - Parkinson's Disease - Implantable Neurostimulator for the Treatment of Parkinson's Disease 27
  • Table 31: Vercise Deep Brain Stimulation System - Parkinson's Disease - Kombinierte Tiefe Hirnstimulation Des Nucleus Subthalamicus Und Nucleus Basalis Meynert Zur Behandlung Der Parkinson-Krankheit Mit Demenz 28
  • Table 32: Vercise Deep Brain Stimulation System - Parkinson's Disease - Registry of Deep Brain Stimulation with the VERCISE System: Vercise DBS Registry 28
  • Table 33: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 34: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Status 29
  • Table 35: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Description 29
  • Table 36: Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 37: Implantable Cooling Therapy Device - Product Status 30
  • Table 38: Implantable Cooling Therapy Device - Product Description 30
  • Table 39: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 40: Neurosonx SR - Home Version - Product Status 31
  • Table 41: Neurosonx SR - Home Version - Product Description 31
  • Table 42: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 43: rTMS H-Coil - Product Status 32
  • Table 44: rTMS H-Coil - Product Description 32
  • Table 45: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 46: ParkinTune - Product Status 33
  • Table 47: ParkinTune - Product Description 33
  • Table 48: Clinatec Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 49: Intracranial Deep Brain Stimulation Device - Product Status 34
  • Table 50: Intracranial Deep Brain Stimulation Device - Product Description 34
  • Table 51: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 52: TOPS Device - Alzheimer's disease - Product Status 35
  • Table 53: TOPS Device - Alzheimer's disease - Product Description 35
  • Table 54: TOPS Device - Depression - Product Status 36
  • Table 55: TOPS Device - Depression - Product Description 36
  • Table 56: TOPS Device - Epilepsy - Product Status 36
  • Table 57: TOPS Device - Epilepsy - Product Description 37
  • Table 58: TOPS Device - Obesity - Product Status 37
  • Table 59: TOPS Device - Obesity - Product Description 37
  • Table 60: TOPS Device - Obsessive-Compulsive Disorder - Product Status 38
  • Table 61: TOPS Device - Obsessive-Compulsive Disorder - Product Description 38
  • Table 62: TOPS Device - Parkinson's disease - Product Status 38
  • Table 63: TOPS Device - Parkinson's disease - Product Description 39
  • Table 64: Duke University Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 65: DBS Electrode - Product Status 40
  • Table 66: DBS Electrode - Product Description 40
  • Table 67: Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 68: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Status 41
  • Table 69: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Description 41
  • Table 70: Functional Neuromodulation Inc. - Ongoing Clinical Trials Overview 42
  • Table 71: Deep Brain Stimulation - Mild Alzheimer's Disease - A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients with Mild Probable Alzheimer's Disease 43
  • Table 72: Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 73: Disposable Surgical Electrode - Product Status 44
  • Table 74: Disposable Surgical Electrode - Product Description 44
  • Table 75: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 76: Triple Halo Coil - Product Status 45
  • Table 77: Triple Halo Coil - Product Description 45
  • Table 78: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 79: Deep Brain Stimulation Device - Product Status 46
  • Table 80: Deep Brain Stimulation Device - Product Description 46
  • Table 81: Deep Brain Stimulation System - Product Status 47
  • Table 82: Deep Brain Stimulation System - Product Description 47
  • Table 83: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 84: Implantable Micro - Cannula Device - Product Status 48
  • Table 85: Implantable Micro - Cannula Device - Product Description 48
  • Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 87: Sensor System - DBS - Product Status 49
  • Table 88: Sensor System - DBS - Product Description 49
  • Table 89: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 90: Activa SC Neurostimulator - Epilepsy - Product Status 50
  • Table 91: Activa SC Neurostimulator - Epilepsy - Product Description 50
  • Table 92: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Status 51
  • Table 93: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Description 51
  • Table 94: Reclaim Deep Brain Stimulation System - Depression - Product Status 51
  • Table 95: Reclaim Deep Brain Stimulation System - Depression - Product Description 52
  • Table 96: Sapiens DBS Field Steering System - Product Status 52
  • Table 97: Sapiens DBS Field Steering System - Product Description 52
  • Table 98: Medtronic plc - Ongoing Clinical Trials Overview 53
  • Table 99: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Medtronic Registry for Epilepsy: MORE 54
  • Table 100: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 101: Responsive Epilepsy Control System-On-Chip - Product Status 55
  • Table 102: Responsive Epilepsy Control System-On-Chip - Product Description 55
  • Table 103: NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 104: Deep Brain Stimulation - Product Status 56
  • Table 105: Deep Brain Stimulation - Product Description 56
  • Table 106: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 107: Deep Brain Stimulation System - Cachexia - Product Status 57
  • Table 108: Deep Brain Stimulation System - Cachexia - Product Description 57
  • Table 109: Deep Brain Stimulation System - Obesity - Product Status 58
  • Table 110: Deep Brain Stimulation System - Obesity - Product Description 58
  • Table 111: Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 112: Implantable Deep Brain Stimulation Device - Product Status 59
  • Table 113: Implantable Deep Brain Stimulation Device - Product Description 59
  • Table 114: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 115: Synapse - Product Status 60
  • Table 116: Synapse - Product Description 60
  • Table 117: Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 118: DSF-rTMS - Product Status 61
  • Table 119: DSF-rTMS - Product Description 61
  • Table 120: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 121: Implantable Electrode - Epilepsy Surgery - Product Status 62
  • Table 122: Implantable Electrode - Epilepsy Surgery - Product Description 62
  • Table 123: Indigenous Deep Brain Stimulation Device - Product Status 63
  • Table 124: Indigenous Deep Brain Stimulation Device - Product Description 63
  • Table 125: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 126: Libra Deep Brain Stimulation System - Depression - Product Status 64
  • Table 127: Libra Deep Brain Stimulation System - Depression - Product Description 64
  • Table 128: Next Generation Implantable DBS System - Primary Cell - Product Status 65
  • Table 129: Next Generation Implantable DBS System - Primary Cell - Product Description 65
  • Table 130: St. Jude Medical LLC - Ongoing Clinical Trials Overview 66
  • Table 131: Libra Deep Brain Stimulation System - Depression - A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression 67
  • Table 132: Libra Deep Brain Stimulation System - Depression - Deep Brain Stimulation for Treatment-Resistant Depression 67
  • Table 133: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 134: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Status 68
  • Table 135: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Description 68
  • Table 136: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 137: Implantable Ultrasound Neuromodulation Device - Product Status 69
  • Table 138: Implantable Ultrasound Neuromodulation Device - Product Description 69
  • Table 139: Wireless Deep Brain Stimulating System - Product Status 70
  • Table 140: Wireless Deep Brain Stimulating System - Product Description 70
  • Table 141: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 142: Deep Brain Stimulation System - Product Status 71
  • Table 143: Deep Brain Stimulation System - Product Description 71
  • Table 144: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 145: Wireless Deep Brain Stimulation System - Essential Tremor - Product Status 72
  • Table 146: Wireless Deep Brain Stimulation System - Essential Tremor - Product Description 72
  • Table 147: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 148: Deep Brain Stimulation System - Product Status 73
  • Table 149: Deep Brain Stimulation System - Product Description 73
  • Table 150: University of Milan Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 151: Implantable Brain Pacemaker - Product Status 74
  • Table 152: Implantable Brain Pacemaker - Product Description 74
  • Table 153: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 154: Adaptive Deep Brain Stimulation System - Product Status 75
  • Table 155: Adaptive Deep Brain Stimulation System - Product Description 75
  • Table 156: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 157: Deep Brain Magnetic Stimulator - Product Status 76
  • Table 158: Deep Brain Magnetic Stimulator - Product Description 76
  • Table 159: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 160: Deep Brain Stimulator - Product Status 77
  • Table 161: Deep Brain Stimulator - Product Description 77
  • Table 162: University of South Florida - Ongoing Clinical Trials Overview 78
  • Table 163: Deep Brain Stimulator - Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients with Primary Dystonia 79
  • Table 164: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 165: DBS10k - Product Status 80
  • Table 166: DBS10k - Product Description 80
  • Table 167: Neural Recording Array - Product Status 81
  • Table 168: Neural Recording Array - Product Description 81
  • Table 169: Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 170: SONS System - Product Status 82
  • Table 171: SONS System - Product Description 82
  • Table 172: Glossary 118

List of Figures

1.2 List of Figures

  • Figure 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 10
  • Figure 2: Deep Brain Stimulators - Pipeline Products by Territory 11
  • Figure 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 12
  • Figure 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 13
  • Figure 5: Deep Brain Stimulators - Ongoing Clinical Trials 14
Back to Top